ArticleBlood2015
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.
Shannon R McCurdy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
170 papers cite itlatest 60 shown
this paperpooled ittrialcites it